There is a current belief among Nuclear Medicine departments that a necessary trade-off exists in acquiring patient-specific dose and the time required to do so. However, knowing the patient-specific dose doesn’t need to add significant time to your workflow. MIM SurePlan MRT provides effective dosimetry, organ and tumor segmentation, deformable registration, and communication tools that improve clinical guidance while reducing effort — all in a single solution.
MIM SurePlan™ MRT
MIM SurePlan MRT provides timesaving tools for organ and tumor segmentation, deformable registration, and voxel-based dosimetry for molecular radiotherapy.
MIM SurePlan MRT provides timesaving tools for organ and tumor segmentation, deformable registration, and voxel-based dosimetry for molecular radiotherapy.
MIM SurePlan LiverY90 provides timesaving tools for liver and tumor segmentation, deformable registration, and post-treatment dosimetry using Y90-PET and Bremsstrahlung SPECT.
MIM SurePlan LiverY90 provides timesaving tools for liver and tumor segmentation, deformable registration, and post-treatment dosimetry using Y90-PET and Bremsstrahlung SPECT.
New Molecular Therapies
Expand the Oncologist’s Toolkit
Molecular Radiotherapies provide a distinct advantage over other systemic therapies: their distribution can be seen and measured, enabling personalization. Absorbed dose has shown to be a useful biomarker of response to radiation therapies. As a result, it has significant potential use in clinical decision-making to achieve the best possible patient outcomes. But is access to patient-specific absorbed dose practical?
Tumor Segmentation
PET Edge®
MIM Software’s proprietary, gradientbased technique segments lesions with a single click.
Speed and Consistency
Experience accurate and reproducible tumor segmentation regardless of who is doing the work.
Advanced Therapy Response
Capture additional therapy response metrics beyond tumor volume, such as SUV peak and tumor burden.
M IM Software is devoted to
providing superior customer
service.
Vendor-Neutral Quantitative Corrections
support for quantitative SPECT reconstruction – ensuring that reconstruction can be performed on your existing cameras. having a vendor-neutral platform can help standardize reconstructions across your department.
AI Auto-Segmentation
Leveraging our experience in Radiation Oncology, MIM Software offers several industry-leading segmentation tools to help you save time in the dosimetry process. our new artificial intelligence platform for automatic segmentation of normal structures, and a single-click tool for tumor segmentation.
Single Timepoint Dosimetry
Single timepoint dosimetry is now available for evaluation in MIM SurePlan MRT. This is a cutting-edge dosimetry process that allows estimation of the absorbed dose with only a single SPECT/CT, further reducing the requirements needed to perform dosimetry.
Multi-Tracer Theranostics
Multiple Molecular Radiotherapy tracers, such as Lutathera Lu-177 dotatate, Azedra I-131 iobenguane, Hicon I-131 NAI for thyroid, and more can be imaged with MIM SurePlan MRT, confirming dose delivery in the patient.
Fully-Automated Registration
Save time and improve accuracy over conventional registration techniques with MIM’s automatic image registration to propagate VOIs between timepoints with minimal or no adjustment.